We demonstrate that these inhibitors suppress SLC15A4-mediated endolysosomal TLR and NOD capabilities in a number of human and mouse immune cells; we offer evidence in their capability to suppress inflammation in vivo and in clinical options; and we provide insights into their mechanism of action. Our conclusions set up https://danielo531mwe0.wikijournalist.com/user